Tags: SOCMA Member News
Monument Chemical has acquired KMTEX LLC, a privately-owned specialty chemical distillations manufacturer based in Port Arthur, Texas.
July 23, 2021
Lonza, a CDMO partner to the biopharma industry, today announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement.
July 16, 2021
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
July 2, 2021
– Sun Chemical will increase prices across a broad portfolio of its packaging and commercial sheetfed inks, coatings, and adhesives in North America, effective July 1, 2021.
June 30, 2021
Colonial Chemical, Inc.
is a winner in the 2021 EPA Green Chemistry Challenge Awards Program, specifically in the focus area of The Design of Greener Chemicals. Colonial Chemical is being recognized for developing Suga®Boost surfactant blends that use more environmentally friendly chemicals than traditional cleaning surfactants.
June 21, 2021
Lonza today announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The expanded collaboration will further extend the manufacture of the drug substance for the COVID-19 Vaccine Moderna and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Geleen (NL) site.
June 2, 2021
– Sun Chemical will increase prices across a broad portfolio of its packaging and commercial sheetfed inks, coatings, and adhesives in North America, effective July 1, 2021.
June 1, 2021
Replacing a chemical reactor is a major undertaking during the best of circumstances, but what happens when this needs to be done during a pandemic – and multiple teams are involved? Is it possible to safely replace equipment worth millions of dollars expected to last 50 years or more?
May 18, 2021
Ott Scientific is pleased to announce its acquisition of American Bionostica, Inc. (ABI), a lateral flow development and manufacturing company, further diversifying the company's product portfolio within the health-care diagnostics space.
May 10, 2021
Lonza today announced significant investments to expand its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US).
May 6, 2021
